论文部分内容阅读
心房颤动(简称房颤,atrial fibrillation,AF)合并心室率过速是临床最常见的心律失常之一,多伴有基础性心脏病,可能导致血栓栓塞和心功能恶化,在无器质性心脏病患者可因长期快速心率反应引起心动过速性心脏病,导致心脏器质性改变。因此,应予以积极治疗,尽快恢复窦性心律。对于房颤合并心室率过速的治疗,治疗方法较多,目前仍以药物治疗为主。本文皆在探讨胺碘酮治疗阵发性房颤合并心室率过速的疗效和安全性。
Atrial fibrillation (atrial fibrillation, AF) combined with ventricular tachycardia is one of the most common clinical arrhythmias, and more associated with underlying heart disease, may lead to thromboembolism and cardiac dysfunction in non-organic heart Patients with heart failure due to long-term rapid response to heart rate heart rate, leading to structural changes in the heart. Therefore, should be actively treated, as soon as possible to restore sinus rhythm. For the treatment of atrial fibrillation and ventricular tachycardia, more treatment is still the main drug treatment. This article are to explore the efficacy and safety of amiodarone in the treatment of paroxysmal atrial fibrillation with ventricular tachycardia.